Ovid Therapeutics Inc. · NASDAQ:OVID

Carter Charles Ross received 50,000 Ovid Therapeutics Inc. shares as an award (Form 4)

Traded Jul 6, 2026 · Filed Jul 8, 2026

On Jul 6, 2026, Carter Charles Ross (Chief Financial Officer) received 50,000 Ovid Therapeutics Inc. shares as an award, leaving 94,375 shares. Filed Jul 8, 2026 (Form 4).

Awarded: 50,000 shares
Holding after: 94,375 shares
Trading plan: No
Role: Chief Financial Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Jul 6, 2026	Common Stock	Award	50,000		94,375	Direct

Source

View original at SEC

Related